Geode Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Geode Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.03M	Buy	815,107 +35,465	+5%	+$245K	﹤0.01%	2967
2025 Q4	$6.38M	Buy	779,642 +6,013	+0.8%	+$44.5K	﹤0.01%	2642
2025 Q3	$5.7M	Sell	773,629 -1,864	-0.2%	-$14.1K	﹤0.01%	2715
2025 Q2	$6.3M	Buy	775,493 +24,995	+3%	+$169K	﹤0.01%	2608
2025 Q1	$5.29M	Buy	750,498 +64,752	+9%	+$402K	﹤0.01%	2624
2024 Q4	$5.1M	Buy	685,746 +88,061	+15%	+$563K	﹤0.01%	2741
2024 Q3	$2.95M	Buy	597,685 +55,703	+10%	+$291K	﹤0.01%	3003
2024 Q2	$2.78M	Buy	541,982 +255,020	+89%	+$1.51M	﹤0.01%	3016
2024 Q1	$1.52M	Buy	286,962 +1,877	+0.7%	+$13.4K	﹤0.01%	3217
2023 Q4	$1.77M	Buy	285,085 +9,175	+3%	+$63.7K	﹤0.01%	3152
2023 Q3	$2.08M	Sell	275,910 -10,667	-4%	-$97.5K	﹤0.01%	3066
2023 Q2	$2.77M	Sell	286,577 -205,813	-42%	-$1.26M	﹤0.01%	3005
2023 Q1	$1.86M	Buy	492,390 +27,175	+6%	+$151K	﹤0.01%	3063
2022 Q4	$3.01M	Buy	465,215 +569	+0.1%	+$4.69K	﹤0.01%	2898
2022 Q3	$4.13M	Sell	464,646 -13,784	-3%	-$140K	﹤0.01%	2770
2022 Q2	$4.77M	Buy	478,430 +6,945	+1%	+$68.8K	﹤0.01%	2724
2022 Q1	$5.46M	Buy	471,485 +10,404	+2%	+$116K	﹤0.01%	2750
2021 Q4	$5.12M	Buy	461,081 +10,287	+2%	+$99.8K	﹤0.01%	2888
2021 Q3	$4.16M	Sell	450,794 -288	-0.1%	-$3.13K	﹤0.01%	3018
2021 Q2	$5.07M	Buy	451,082 +28,122	+7%	+$324K	﹤0.01%	2901
2021 Q1	$4.48M	Buy	422,960 +6,778	+2%	+$76.2K	﹤0.01%	2847
2020 Q4	$4.51M	Sell	416,182 -14,434	-3%	-$149K	﹤0.01%	2657
2020 Q3	$4.18M	Buy	430,616 +9,449	+2%	+$90K	﹤0.01%	2504
2020 Q2	$3.35M	Buy	421,167 +3,379	+0.8%	+$34.9K	﹤0.01%	2548
2020 Q1	$3.63M	Buy	417,788 +44,419	+12%	+$462K	﹤0.01%	2335
2019 Q4	$4.22M	Buy	373,369 +11,710	+3%	+$125K	﹤0.01%	2563
2019 Q3	$3.93M	Buy	361,659 +13,036	+4%	+$142K	﹤0.01%	2527
2019 Q2	$3.27M	Buy	348,623 +15,099	+5%	+$152K	﹤0.01%	2641
2019 Q1	$4.09M	Buy	333,524 +55,413	+20%	+$676K	﹤0.01%	2447
2018 Q4	$3.29M	Buy	278,111 +14,642	+6%	+$201K	﹤0.01%	2482
2018 Q3	$3.79M	Buy	263,469 +12,456	+5%	+$172K	﹤0.01%	2537
2018 Q2	$3.74M	Buy	251,013 +24,311	+11%	+$338K	﹤0.01%	2504
2018 Q1	$2.96M	Buy	226,702 +2,038	+0.9%	+$26.8K	﹤0.01%	2548
2017 Q4	$2.83M	Buy	224,664 +1,521	+0.7%	+$19.2K	﹤0.01%	2555
2017 Q3	$2.89M	Buy	223,143 +9,333	+4%	+$123K	﹤0.01%	2535
2017 Q2	$3.17M	Buy	213,810 +968	+0.5%	+$13.5K	﹤0.01%	2456
2017 Q1	$2.55M	Buy	212,842 +9,813	+5%	+$124K	﹤0.01%	2517
2016 Q4	$2.8M	Buy	203,029 +8,771	+5%	+$122K	﹤0.01%	2435
2016 Q3	$2.6M	Buy	194,258 +2,454	+1%	+$29.7K	﹤0.01%	2394
2016 Q2	$2.06M	Buy	191,804 +1,306	+0.7%	+$14.4K	﹤0.01%	2459
2016 Q1	$2K	Buy	190,498 +18,461	+11%	+$203K	﹤0.01%	2462
2015 Q4	$2.04M	Buy	172,037 +875	+0.5%	+$10.7K	﹤0.01%	2469
2015 Q3	$2M	Buy	171,162 +1,580	+0.9%	+$20.9K	﹤0.01%	2443
2015 Q2	$2.45M	Buy	169,582 +11,536	+7%	+$166K	﹤0.01%	2371
2015 Q1	$2.2M	Buy	158,046 +5,037	+3%	+$69.6K	﹤0.01%	2377
2014 Q4	$2.11M	Buy	153,009 +2,032	+1%	+$26.3K	﹤0.01%	2391
2014 Q3	$1.85M	Buy	150,977 +2,688	+2%	+$33.6K	﹤0.01%	2406
2014 Q2	$1.85M	Sell	148,289 -17,348	-10%	-$204K	﹤0.01%	2414
2014 Q1	$1.85M	Sell	165,637 -2,031	-1%	-$22.3K	﹤0.01%	2385
2013 Q4	$2.03M	Buy	167,668 +26,577	+19%	+$317K	﹤0.01%	2279
2013 Q3	$1.72M	Buy	141,091 +4,438	+3%	+$61.9K	﹤0.01%	2254
2013 Q2	$1.8M	Buy	+136,653	New	+$1.89M	﹤0.01%	2107

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return